Substance Use Disorders (SUDs) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date : 2021-03-14 | Publisher : 99Strategy | No Of Page : 93 | Report Id : MRB000116649 |

   

Report

MRB

Substance Use Disorders (SUDs) Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Publish Date: 2021-03-14 No Of Page: 93 Report Id: MRB000116649 Publisher: 99Strategy Category: Medical Care

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use Chapter 8: South America Market Segmentation by region, type and End-Use Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use. Chapter 10: Market Competition by Companies Chapter 11: Market forecast and environment forecast. Chapter 12: Industry Summary. The global Substance Use Disorders (SUDs) Treatment market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics. Based on the type of product, the global Substance Use Disorders (SUDs) Treatment market segmented into Opioid Addiction Tobacco/Nicotine Addiction Alcohol Dependence Based on the end-use, the global Substance Use Disorders (SUDs) Treatment market classified into Hospital & Clinics Residential (non-hospital) Based on geography, the global Substance Use Disorders (SUDs) Treatment market segmented into North America [U.S., Canada, Mexico] Europe [Germany, UK, France, Italy, Rest of Europe] Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific] South America [Brazil, Argentina, Rest of Latin America] Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa] And the major players included in the report are Indivior Pfizer Alkermes Novartis Mylan Cipla Glenmark Dr. Reddy's Laboratories Teva Pharmaceutical

Table of Contents 1 RESEARCH SCOPE 1.1 Research Product Definition 1.2 Research Segmentation 1.2.1 Product Type 1.2.2 Main product Type of Major Players 1.3 Demand Overview 1.4 Research Methodology 2 GLOBAL SUBSTANCE USE DISORDERS (SUDS) TREATMENT INDUSTRY 2.1 Summary about Substance Use Disorders (SUDs) Treatment Industry 2.2 Substance Use Disorders (SUDs) Treatment Market Trends 2.2.1 Substance Use Disorders (SUDs) Treatment Production & Consumption Trends 2.2.2 Substance Use Disorders (SUDs) Treatment Demand Structure Trends 2.3 Substance Use Disorders (SUDs) Treatment Cost & Price 3 MARKET DYNAMICS 3.1 Manufacturing & Purchasing Behavior in 2020 3.2 Market Development under the Impact of COVID-19 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunity 3.2.4 Risk 4 GLOBAL MARKET SEGMENTATION 4.1 Region Segmentation (2017 to 2021f) 4.1.1 North America (U.S., Canada and Mexico) 4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe) 4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific) 4.1.4 South America (Brazil,, Argentina, Rest of Latin America) 4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) 4.2 Product Type Segmentation (2017 to 2021f) 4.2.1 Opioid Addiction 4.2.2 Tobacco/Nicotine Addiction 4.2.3 Alcohol Dependence 4.3 Consumption Segmentation (2017 to 2021f) 4.3.1 Hospital & Clinics 4.3.2 Residential (non-hospital) 5 NORTH AMERICA MARKET SEGMENT 5.1 Region Segmentation (2017 to 2021f) 5.1.1 U.S. 5.1.2 Canada 5.1.3 Mexico 5.2 Product Type Segmentation (2017 to 2021f) 5.2.1 Opioid Addiction 5.2.2 Tobacco/Nicotine Addiction 5.2.3 Alcohol Dependence 5.3 Consumption Segmentation (2017 to 2021f) 5.3.1 Hospital & Clinics 5.3.2 Residential (non-hospital) 5.4 Impact of COVID-19 in North America 6 EUROPE MARKET SEGMENTATION 6.1 Region Segmentation (2017 to 2021f) 6.1.1 Germany 6.1.2 UK 6.1.3 France 6.1.4 Italy 6.1.5 Rest of Europe 6.2 Product Type Segmentation (2017 to 2021f) 6.2.1 Opioid Addiction 6.2.2 Tobacco/Nicotine Addiction 6.2.3 Alcohol Dependence 6.3 Consumption Segmentation (2017 to 2021f) 6.3.1 Hospital & Clinics 6.3.2 Residential (non-hospital) 6.4 Impact of COVID-19 in Europe 7 ASIA-PACIFIC MARKET SEGMENTATION 7.1 Region Segmentation (2017 to 2021f) 7.1.1 China 7.1.2 India 7.1.3 Japan 7.1.4 South Korea 7.1.5 Southeast Asia 7.1.6 Australia 7.1.7 Rest of Asia Pacific 7.2 Product Type Segmentation (2017 to 2021f) 7.2.1 Opioid Addiction 7.2.2 Tobacco/Nicotine Addiction 7.2.3 Alcohol Dependence 7.3 Consumption Segmentation (2017 to 2021f) 7.3.1 Hospital & Clinics 7.3.2 Residential (non-hospital) 7.4 Impact of COVID-19 in Europe 8 SOUTH AMERICA MARKET SEGMENTATION 8.1 Region Segmentation (2017 to 2021f) 8.1.1 Brazil 8.1.2 Argentina 8.1.3 Rest of Latin America 8.2 Product Type Segmentation (2017 to 2021f) 8.2.1 Opioid Addiction 8.2.2 Tobacco/Nicotine Addiction 8.2.3 Alcohol Dependence 8.3 Consumption Segmentation (2017 to 2021f) 8.3.1 Hospital & Clinics 8.3.2 Residential (non-hospital) 8.4 Impact of COVID-19 in Europe 9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION 9.1 Region Segmentation (2017 to 2021f) 9.1.1 GCC 9.1.2 North Africa 9.1.3 South Africa 9.1.4 Rest of Middle East and Africa 9.2 Product Type Segmentation (2017 to 2021f) 9.2.1 Opioid Addiction 9.2.2 Tobacco/Nicotine Addiction 9.2.3 Alcohol Dependence 9.3 Consumption Segmentation (2017 to 2021f) 9.3.1 Hospital & Clinics 9.3.2 Residential (non-hospital) 9.4 Impact of COVID-19 in Europe 10 COMPETITION OF MAJOR PLAYERS 10.1 Brief Introduction of Major Players 10.1.1 Indivior 10.1.2 Pfizer 10.1.3 Alkermes 10.1.4 Novartis 10.1.5 Mylan 10.1.6 Cipla 10.1.7 Glenmark 10.1.8 Dr. Reddy's Laboratories 10.1.9 Teva Pharmaceutical 10.2 Substance Use Disorders (SUDs) Treatment Sales Date of Major Players (2017-2020e) 10.2.1 Indivior 10.2.2 Pfizer 10.2.3 Alkermes 10.2.4 Novartis 10.2.5 Mylan 10.2.6 Cipla 10.2.7 Glenmark 10.2.8 Dr. Reddy's Laboratories 10.2.9 Teva Pharmaceutical 10.3 Market Distribution of Major Players 10.4 Global Competition Segmentation 11 MARKET FORECAST 11.1 Forecast by Region 11.2 Forecast by Demand 11.3 Environment Forecast 11.3.1 Impact of COVID-19 11.3.2 Geopolitics Overview 11.3.3 Economic Overview of Major Countries 12 REPORT SUMMARY STATEMENT

List of Table 1.Table Substance Use Disorders (SUDs) Treatment Product Type Overview 2.Table Substance Use Disorders (SUDs) Treatment Product Type Market Share List 3.Table Substance Use Disorders (SUDs) Treatment Product Type of Major Players 4.Table Brief Introduction of Indivior 5.Table Brief Introduction of Pfizer 6.Table Brief Introduction of Alkermes 7.Table Brief Introduction of Novartis 8.Table Brief Introduction of Mylan 9.Table Brief Introduction of Cipla 10.Table Brief Introduction of Glenmark 11.Table Brief Introduction of Dr. Reddy's Laboratories 12.Table Brief Introduction of Teva Pharmaceutical 13.Table Products & Services of Indivior 14.Table Products & Services of Pfizer 15.Table Products & Services of Alkermes 16.Table Products & Services of Novartis 17.Table Products & Services of Mylan 18.Table Products & Services of Cipla 19.Table Products & Services of Glenmark 20.Table Products & Services of Dr. Reddy's Laboratories 21.Table Products & Services of Teva Pharmaceutical 22.Table Market Distribution of Major Players 23.Table Global Major Players Sales Revenue (Million USD) 2017-2020e 24.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e 25.Table Global Substance Use Disorders (SUDs) Treatment Market Forecast (Million USD) by Region 2021f-2026f 26.Table Global Substance Use Disorders (SUDs) Treatment Market Forecast (Million USD) Share by Region 2021f-2026f 27.Table Global Substance Use Disorders (SUDs) Treatment Market Forecast (Million USD) by Demand 2021f-2026f 28.Table Global Substance Use Disorders (SUDs) Treatment Market Forecast (Million USD) Share by Demand 2021f-2026f

Topical Use Acne Treatment Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segme ...
Published Date :  2021-03-14

2015-2025 Global Dental Trauma Treatment Market Research by Type, End-Use and Region

Summary The global Dental Trauma Treatment market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and Seg ...
Published Date :  2020-10-20

2015-2025 Global Actinic Keratosis Treatment Market Research by Type, End-Use and Region

Summary The global Actinic Keratosis Treatment market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market Definition and ...
Published Date :  2020-10-20

2015-2025 Global Prostate Specific Antigen (PSA) Biomarker Market Research by Type, End-Use and Region

Summary The global Prostate Specific Antigen (PSA) Biomarker market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapter 1: Market ...
Published Date :  2020-10-20

2015-2025 Global Prostate Specific Antigen (PSA) Blood Based Biomarker Market Research by Type, End-Use and Region

Summary The global Prostate Specific Antigen (PSA) Blood Based Biomarker market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025. Further key aspects of the report indicate that: Chapte ...
Published Date :  2020-10-20